Interleukin-6 gene expression is preferentially restricted in VLA-5-MPC-1- immature but not in VLA-5+MPC-1+ mature myeloma cells

Int J Hematol. 1996 Apr;63(3):215-26. doi: 10.1016/0925-5710(96)00439-2.

Abstract

Interleukin-6 (IL-6) is essential for the proliferation of myeloma cells, and IL-6 is considered to be produced from not only myeloma cells themselves but also microenvironments including stromal cells. To clarify which subpopulation of myeloma cells can produce IL-6, we examined IL-6 mRNA expression in immature and mature myeloma cells and normal plasma cells by RT-PCR. IL-6 mRNA expression was found in all (10/10) specimens of sorted VLA-5-MPC-1- immature myeloma cells and 27% (3/11) of VLA-5-MPC-1+ myeloma cells. On the contrary, no IL-6 mRNA was expressed in VLA-5+MPC-1+ mature myeloma cells (0/4) and CD19+CD56- normal plasma cells (0/5). IL-6R gene expression was detected in all normal and malignant plasma cells without exception. Therefore, these findings suggest that IL-6 production is preferentially restricted in immature not mature myeloma cells, and this may explain why immature myeloma cells show greater proliferative activity.

MeSH terms

  • Base Sequence
  • Gene Expression Regulation, Neoplastic*
  • Humans
  • Interleukin-6 / genetics*
  • Molecular Sequence Data
  • Multiple Myeloma / genetics*
  • Multiple Myeloma / immunology
  • Neoplasm Proteins / metabolism*
  • Polymerase Chain Reaction
  • Receptors, Fibronectin / metabolism*
  • Tumor Cells, Cultured / immunology
  • Tumor Cells, Cultured / pathology

Substances

  • Interleukin-6
  • MPC-1 antigen
  • Neoplasm Proteins
  • Receptors, Fibronectin